Publication | Open Access
Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment
25
Citations
58
References
2024
Year
Immune checkpoint inhibitors exert clinical efficacy against various types of cancer through reinvigoration of exhausted CD8<sup>+</sup> T cells that attack cancer cells directly in the tumor microenvironment (TME). Using single-cell sequencing and mouse models, we show that CXCL13, highly expressed in tumor-infiltrating exhausted CD8<sup>+</sup> T cells, induces CD4<sup>+</sup> follicular helper T (T<sub>FH</sub>) cell infiltration, contributing to anti-tumor immunity. Furthermore, a part of the T<sub>FH</sub> cells in the TME exhibits cytotoxicity and directly attacks major histocompatibility complex-II-expressing tumors. T<sub>FH</sub>-like cytotoxic CD4<sup>+</sup> T cells have high LAG-3/BLIMP1 and low TCF1 expression without self-renewal ability, whereas non-cytotoxic T<sub>FH</sub> cells express low LAG-3/BLIMP1 and high TCF1 with self-renewal ability, closely resembling the relationship between terminally differentiated and stem-like progenitor exhaustion in CD8<sup>+</sup> T cells, respectively. Our findings provide deep insights into T<sub>FH</sub>-like CD4<sup>+</sup> T cell exhaustion with helper progenitor and cytotoxic differentiated functions, mediating anti-tumor immunity orchestrally with CD8<sup>+</sup> T cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1